Company news

Orthocell Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Orthocell commences nerve repair study

April 17, 2023

Leading US-based nerve surgeons appointed to advisory board

March 28, 2023

Half Yearly Report and Accounts

February 28, 2023

Appendix 4C - Quarterly

January 30, 2023

Remplir Gains Australian Reimbursement

October 31, 2022

OrthoATI Rotator Cuff Study Success With Cross-Over Patients

September 28, 2022

First orders for Striate and Remplir

September 26, 2022

Appointment of Exclusive Australian Distributor for Remplir

September 7, 2022

Final Report and Annual Report to Shareholders

August 30, 2022

Striate Global License and Distribution Agreement Update

July 20, 2022

OCC Signs Striate Global License And Manufacturing Agreement

June 27, 2022

Final Data Readout for Orthocells Nerve Reconstruction Study

June 6, 2022

Orthocell Receives A$2.1m R&D Tax Incentive Refund

June 2, 2022

Notification regarding unquoted securities - OCC

April 21, 2022

Regulatory Approval for Remplir Nerve Repair Device

March 20, 2022

Striate US Market Entry Update

February 27, 2022

Application for quotation of securities - OCC

December 30, 2021

Successful SmrtGraft Shoulder Study Published

December 15, 2021

OrthoATI Tendon Clinical Study Success

December 7, 2021

Ortho-ATI Shoulder Tendon Study Database Lock

November 14, 2021

Application for quotation of securities - OCC

November 9, 2021

Positive Data for CelGro Collagen Rope in ACL Reconstruction

September 14, 2021

OCC Secures Patents for Suture-Less Repair of Soft Tissue

September 7, 2021

Ortho-ATI Shoulder Tendon Study Update Revised

August 31, 2021

Ortho-ATI Shoulder Tendon Study Update

August 30, 2021

Appendix 4E and Annual Report to Shareholders

August 27, 2021

CelGro Facilitates Lymphatic Vessel Regeneration Updated

August 2, 2021

CelGro Facilitates Lymphatic Vessel Regeneration

August 1, 2021

Orthocell Appoints Exclusive Distributor in Australia

July 13, 2021

Positive CelGro Nerve Regeneration Results

June 20, 2021

OCC Secures Patents for Sutureless Repair of Soft Tissue

June 15, 2021

New Collagen Rope Patent for CelGro Platform Technology

May 25, 2021

CelGro Study Results Open Up New US Market Access Strategy

April 27, 2021

CelGro gains Australian reimbursement

March 2, 2021

Orthocell receives new US patent for CelGro

February 15, 2021

CelGro Recommended for Reimbursement

February 4, 2021

Orthocell Receives A$2.3m R&D Tax Incentive Refund

January 19, 2021

Orthocell Receives US Market Clearance

January 15, 2021

Orthocell Receives First US CelGro Product Approval

January 13, 2021

CelGro Receives Australian Market Approval

December 22, 2020

CelGro Completes Pivotal Step in TGA Approval Process

December 16, 2020

Positive Results in CelGro Nerve Repair Study

November 19, 2020

CelGro Bone Regeneration in Dental & Orthopedic Applications

September 16, 2020

CelGro Nerve Repair AUS Regulatory Application Submitted

July 29, 2020

Orthocells Ortho-ATI Shows 87.5% Success Rate

July 8, 2020

CelGro US 510(k) Submission Completed

May 11, 2020

Successful CelGro US Bone Repair Study

March 10, 2020

US Nerve Repair Study Design Meets FDA Requirements

December 15, 2019

SPP Offer Document and Terms And Conditions

December 5, 2019

Placement and Share Purchase Plan

December 3, 2019

← Newer news releases · Older news releases →

Decks

The 5 newest of 35 decks. Every deck is listed under its year.